Volume 39, 1993 AUTHOR INDEX - Clinical Chemistry
Volume 39, 1993 AUTHOR INDEX - Clinical Chemistry
Volume 39, 1993 AUTHOR INDEX - Clinical Chemistry
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
selective removal of -microglobulin from<br />
plasma specimens of long-term<br />
heniodielysis patients by high-performance<br />
immunoaffinity chromatog.(SN), 277<br />
Anabolic steroids<br />
potential use of ketoconazole in dynamic<br />
endocrine test to differentiate between biol.<br />
outliers and testosterone use by athletes,<br />
1798<br />
Analytical error<br />
See also Variation, source of<br />
anal, goals developed from inherent error of<br />
medical tests(S), 1481<br />
anal, inaccuracy for folic acid with a popular<br />
comm. vitamin B15/folate kit(L), 2209<br />
characterization and mathematical<br />
correction of hamolyeis interference in<br />
selected Hitachi 717 assays, 1804<br />
desirable performance criteria for quant<br />
meas. in med. labs, based on biol. analyte<br />
variation-hindrances to reaching some<br />
and reasons to surpass eome(L), 913<br />
detect, of analytically significant error in<br />
endocrine proficiency test results: appin. to<br />
Abbott IMxl(A), 1228<br />
dipyrone interference on several common<br />
biochem. teata(SN), 1033<br />
avaln, of evacuated blood-collection tubes:<br />
effects of 3 types of polymeric separators<br />
on therapeutic drug-monitoring<br />
specimens(SN), 1712<br />
inaccuracy of osmomatry for mess. of plasma<br />
water in acute diabetes mallitua(SN), 1079<br />
intraindividual variation of GHb:<br />
implications for interpretation and anal.<br />
goals, 2305<br />
mess, of cerboxyhemoglobin and total Rb by<br />
5 specialized spectrophotometers<br />
(CO-oximaters) in comparison with ref.<br />
methods(SN),1683<br />
medically relevant lab, performance goals:<br />
listing of complexities and call for<br />
action(S), 1530<br />
method for detg. ref. changes from patients’<br />
serial data: cardiac enzymes, 2298<br />
resoln. and med. utffity frequency improves<br />
on minimum distinguishable differenca(L),<br />
1549<br />
tolerance limits for short-term anal, bias and<br />
anal, imprecision derived from cha. assay<br />
specificity(S), 1514<br />
total error assessment of 5 methods for<br />
cholesterol screening (SN), 297<br />
unusual thermolability properties of<br />
leukocyte -hexosaminidaee: implications<br />
in screening for carriers of Tay-Sachs die.,<br />
1811<br />
using total error to monitor performance,<br />
qualify reagents and calibrators, and select<br />
protocols-real world applns.(A), 1227<br />
Androgen<br />
different steroidogenic pathways involved in<br />
idiopathic and hyperandroganic hirsute<br />
patiente(A), 1168<br />
potential use of ketoconazole in dynamic<br />
endocrine test to differentiate between biol.<br />
outliers and testosterone use by athletes,<br />
1798<br />
prodn. of recombinant androgan receptor in a<br />
heterologous expression system(S), 346<br />
Androatenedlone<br />
interference of lysophoephatidylcholine in<br />
hormone RIAs(SN), 865<br />
181Ifrect androstendione kit: need for<br />
inclusion of extn. step(A), 1265<br />
Anemia<br />
avaln. of anemia in patients receiving total<br />
peranteral nutrition(A), 1196<br />
Fe-deficiency anemia and thalassemia trait<br />
differentiated by simple hematologic tests<br />
and serum Fe concs,, 2271<br />
rapid detn, of erythrocyte pyruvate kinasa<br />
acty.(SN), 512<br />
Anesthesia<br />
medical-care systems for long duration space<br />
missions (R), 13<br />
Anglomorphogenesls<br />
ribokine-induced angiomorphoganeais in<br />
vitro as substitute for animal expts.(A),<br />
1147<br />
2574 CLINICAL CHEMISTRY, Vol. <strong>39</strong>, No. 12, <strong>1993</strong><br />
Anglotensin<br />
develop, of ifiA on coated tubes for<br />
angiotensin U(A), 1169<br />
Anglotensln-convertlng enzyme<br />
kinetic methods for angiotenain-converting<br />
enzyme in plasma(SN), 312<br />
simplified enzymatic assay of angiotensinconverting<br />
enzyme in serum, 400<br />
AntI-.treptoly.ln 0<br />
evaln, of Beckman Vigil liq. quality control<br />
serum for MO, RHF, and CRP(A), 1226<br />
Antlarrhythmlc drug.<br />
See also specific drugs<br />
cm. mess, of serum amiodarone and<br />
desethylamiodarone by using solid-phase<br />
extn. followed by HPLC with a high-carbon<br />
reversed-phase column(SN), 497<br />
Antibodies<br />
See also Autoantibodias<br />
Chagasic Ab positive blood donor prevalence<br />
in U.S., Hispanic surname populations(A),<br />
1246<br />
chemiluminescent assay to detect antibodies<br />
to RNP(A), 11<strong>39</strong><br />
chemuluminescent assays for detect, of<br />
antibodies to La and Ro(A), 1140<br />
effect of prewashing on plastics with<br />
detergents on immunoreactivity of<br />
immobilized antibodies(A), 1272<br />
elevation of tumor necrosis factor-u binding<br />
proteins in patients with anti-neutrophil<br />
cytoplasmic antibodies(A), 1138<br />
latex agglutination test for detecting Abs to<br />
Treponema pdllidism(SN), 1700<br />
sandwich enzyme immunoassay of<br />
osteocalcin in serum with use of antibody<br />
against human osteocalcin, 942<br />
tumor necrosis factor l gene polymorphism<br />
assocd, to islet cell antibodies in type 1<br />
diabetic patiants(A), 1141<br />
Antibodies, anti-Idlotypic<br />
monitoring CA 125 in ovarian cancer<br />
patients administered ‘811-labeled F(ab’)2<br />
fragments of 0C125 antibody(SN), 891<br />
Antibodies, anti-nuclear<br />
ANA-Tutor: computer program that teaches<br />
anti-nuclear Ab test(A), 1223<br />
image anal, system assisting<br />
immunofluoreacence assay for antinuclear<br />
antibodies(A), 1137<br />
Antibodies, blocking<br />
detect, and characterization of blocking-type<br />
anti- acetylcholine receptor antibodies in<br />
sara from patients with myasthania gravis,<br />
2053<br />
Antibodies, chimeric<br />
molecular engineering: applns, to cm.<br />
lab.(S), 1988<br />
Antibodies, heterophific<br />
haterologous double-determinant IRMA:<br />
second-generation immunoassay for detg.<br />
CA 125 in serum(SN), 2509<br />
interference due to heterophilic antibodies in<br />
immunometric assays(A), 1268<br />
modified method for datg. CEA in presence of<br />
human anti-murine antibodies(SN), 522<br />
monitoring CA 125 in ovarian cancer<br />
patients administered ‘81I-labeled F(ab’)2<br />
fragments of OC125 antibody(SN), 891<br />
Antibodies, monoclonal<br />
cardiac-specific immunoenzymometric assay<br />
of troponin i in early phase of acute<br />
myocardial infarction, 972<br />
cha. appins. of serum and tissue markers in<br />
malignant die.: breast cancer as<br />
paradigm(S), 2404<br />
Cobes PP reagent for valproic acid using<br />
monoclonal Ab(A), 1240<br />
comparison of CeG(Nva2-cyclosporin) conca.<br />
mess, in whole blood by monoclonal FPIA,<br />
monoclonal RIA, and HPLC(SN), 1050<br />
detect. of large monoclonal IgG(y) heavy<br />
chain in myeloma sarum(A), 1131<br />
develop, and characterization of monoclonal<br />
Abs specific for cardiac troponin 1(A), 1133<br />
enzyme immunoessay for intact human<br />
insulin in serum or plasma, 578<br />
apitope mapping of monoclonal Abe to<br />
conformational determinants of C-reactive<br />
protein(A), 1255<br />
estn. of PSA by poly.monoclonal ACS PSA<br />
assay vs partial estn. by mono-monoclonal<br />
assay(A), 1190<br />
evain, of colorectal cencer-aaeocd. mucin CA<br />
M43 assay in serum(SN), 1029<br />
evaln. of EMiT CsA assay for use with whole<br />
blood, 2235<br />
hapten-hatarologous conjugates evald. for<br />
appln. to FF4 immunoaeaaye(SN), 256<br />
heteromyaloma cell line for B lymphocyte<br />
immortalization: product. of monoclonal<br />
Abe against HBV(A), 1138<br />
highly sensitive enzyme immunoassay of<br />
proinsulin immunoreactivity with use of 2<br />
monoclonal Abs(SN), 2146<br />
human anti-mouse antibodies against<br />
OC-125 do not interfere in CA- 125 assay<br />
that uses OC-125 and Mu antibodiee(L),<br />
1556<br />
liposome-based flow-injection immunoassay<br />
for det,g. theophylline in serum, 386<br />
modified method for detg. CEA in the<br />
presence of human anti-murine<br />
antibodiea(SN), 522<br />
molecular engineering: applns. to din.<br />
lab.(S), 1988<br />
monitoring of OKT3 serum concs. using<br />
cartridge-based enzyme immunoaaeay(A),<br />
1218<br />
monoclonal Abs specific for prothrombin<br />
fragment 1,2 and use in quant. ELISA,<br />
583<br />
monoclonal Ab-based iinmunoenzymoinetric<br />
assays of retinol -binding protein, 472<br />
multiple forms of PSA in serum: variances in<br />
immunorecognition between monoclonal<br />
and polyclonal assays, 2483<br />
one-step competitive immunochromatog.<br />
assay for semiquant. data, of Lp(a) in<br />
plasma, 619<br />
overview of monoclonal Abe: issues for cm.<br />
pathologist(A), 1109<br />
pyrophosphatase-based ELISA of total 1gB in<br />
serum(SN), 846<br />
quanta. of Lp(a) particles containing various<br />
apo(a) isoforms by a monoclonal<br />
anti-apo(a) capture antibody and<br />
polyclonal anti-apo B detect. antibody<br />
sandwich enzyme immunoassay, 1382<br />
role of antibody valency in haptenheterologous<br />
immunoassays(SN), 879<br />
Syva Emit 2000 vancomycin assay(A), 1245<br />
time-resolved iminunofluorometric assay of<br />
human growth hormone, 1620<br />
transcriptionally amplified DNA probe assay<br />
with ligatable probes and immunochem.<br />
detect.(S), 1934<br />
unique monoclonals to chicken egg yolk<br />
Iga(A), 1251<br />
Antibodies, polyclonal<br />
multiple forms of PSA in serum: variances in<br />
immunorecognition between monoclonal<br />
and polyclonal assays, 2483<br />
time-resolved immunofluorometric assay of<br />
human growth hormone, 1620<br />
Antichymotrypein<br />
assay of complexed ct1-antichymotrypsin in<br />
plasma(SN), 869<br />
double-label time-resolved<br />
immunofluorometric assay of PSA and of<br />
its complexes with u1-antichymotrypsin,<br />
2098<br />
Anticoagulant.<br />
choice of anticoagulant affects mess, of<br />
plasma flbrinogen(L), 1754<br />
Antloonvulsant drug.<br />
intra- and interlab, sources of imprecision in<br />
drug meas, by different techniquee(SN),<br />
851<br />
Antidepressant.<br />
anal. of atypical antidepreseants using HPLC<br />
method for tricycics: solid vs liq. extn.(A),<br />
1241<br />
quant. anal, of tricyclic antidepresaants by<br />
miceller alectrokinetic capillary<br />
chromatog.(A), 12<strong>39</strong><br />
Antioxidant.<br />
free radicals: introduction(A), 1305<br />
roles of oxidants and antiozidants in<br />
pathogenesis of atherosclerosis, 1305